Summit Partners Public Asset Management’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-238,595
Closed -$16.2M 190
2022
Q2
$16.2M Sell
238,595
-39,268
-14% -$2.82M 0.73% 46
2022
Q1
$25.2M Buy
+277,863
New +$22.7M 0.9% 38
2021
Q2
Sell
-159,432
Closed -$17.1M 138
2021
Q1
$17.1M Sell
159,432
-22,371
-12% -$2.32M 0.74% 52
2020
Q4
$15.9M Buy
+181,803
New +$12.8M 0.71% 46
2020
Q3
Sell
-60,000
Closed -$2.91M 120
2020
Q2
$2.91M Buy
+60,000
New +$2.87M 0.17% 87

Other funds holding NARI

Summit Partners Public Asset Management's NARI Position: Q3 2022 in Review

Summit Partners Public Asset Management sold out of Inari Medical, Inc. Common Stock (NARI) in Q3 2022, closing a stake of 238,595 shares — an estimated $16.2M sold.

Summit Partners Public Asset Management first reported a position in NARI in Q2 2020 and held it in 5 quarters. The position peaked at $25.2M in Q1 2022. 240 funds tracked by Wall St. Rank hold NARI as of Q3 2022.

  • Summit Partners Public Asset Management reported no remaining Inari Medical, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Summit Partners Public Asset Management sold 238,595 Inari Medical, Inc. Common Stock shares in Q3 2022, an estimated $16.2M.
  • Summit Partners Public Asset Management first reported a position in Inari Medical, Inc. Common Stock in Q2 2020 and held it in 5 quarters.
  • Summit Partners Public Asset Management's Inari Medical, Inc. Common Stock position peaked at $25.2M in Q1 2022.
  • 240 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q3 2022.

Based on Summit Partners Public Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.